CRISPR/Cas9-Correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer’s PSEN2 N141I neurons
Maitane Ortiz‐Virumbrales(Icahn School of Medicine at Mount Sinai), Sam Gandy(James J. Peters VA Medical Center)
Cited by 169
Related Papers
Diabetes-Associated SorCS1 Regulates Alzheimer's Amyloid-β Metabolism: Evidence for Involvement of SorL1 and the Retromer Complex
|Journal of Neuroscience|2010|188
Group II Metabotropic Glutamate Receptor Stimulation Triggers Production and Release of Alzheimer's Amyloid β<sub>42</sub>from Isolated Intact Nerve Terminals
|Journal of Neuroscience|2010|85
iPSC-derived familial Alzheimer’s PSEN2 N141I cholinergic neurons exhibit mutation-dependent molecular pathology corrected by insulin signaling
|Molecular Neurodegeneration|2018|55
Protein Sorting Motifs in the Cytoplasmic Tail of SorCS1 Control Generation of Alzheimer's Amyloid-β Peptide
|Journal of Neuroscience|2013|42